X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (437) 437
Publication (61) 61
Book / eBook (5) 5
Newspaper Article (2) 2
Book Chapter (1) 1
Book Review (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (225) 225
hematology (184) 184
female (130) 130
male (129) 129
index medicus (128) 128
middle aged (111) 111
adult (110) 110
aged (74) 74
chronic myelogenous leukemia (68) 68
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (64) 64
imatinib mesylate (61) 61
transplantation (58) 58
oncology (51) 51
adolescent (50) 50
benzamides (50) 50
treatment outcome (49) 49
pyrimidines - therapeutic use (46) 46
antineoplastic agents - therapeutic use (43) 43
piperazines - therapeutic use (43) 43
leukemia (41) 41
transplantation, homologous (41) 41
prognosis (40) 40
stem cells (39) 39
therapy (39) 39
hematopoietic stem cell transplantation (38) 38
leukemia, myelogenous, chronic, bcr-abl positive - genetics (38) 38
chronic myeloid-leukemia (37) 37
leukemia, myelogenous, chronic, bcr-abl positive - therapy (37) 37
bone-marrow-transplantation (34) 34
chronic myeloid leukemia (33) 33
retrospective studies (32) 32
hemic and lymphatic diseases (31) 31
abridged index medicus (29) 29
child (28) 28
imatinib (28) 28
survival rate (28) 28
cml (27) 27
multiple myeloma (27) 27
stem-cell transplantation (27) 27
disease-free survival (26) 26
survival (26) 26
cancer (25) 25
protein kinase inhibitors - therapeutic use (25) 25
fusion proteins, bcr-abl - genetics (24) 24
time factors (24) 24
young adult (23) 23
bone marrow (22) 22
chemotherapy (22) 22
hematopoietic stem cells (22) 22
recurrence (22) 22
risk factors (22) 22
versus-host-disease (22) 22
follow-up studies (21) 21
hematology, oncology and palliative medicine (21) 21
leukemia, myelogenous, chronic, bcr-abl positive - mortality (21) 21
stem cell transplantation (21) 21
survival analysis (21) 21
transplantation, autologous (21) 21
bone-marrow transplantation (20) 20
dasatinib (20) 20
immunology (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - pathology (19) 19
aged, 80 and over (18) 18
chronic-phase (18) 18
hematopoietic stem cell transplantation - methods (18) 18
remission induction (17) 17
analysis (16) 16
bone marrow transplantation (16) 16
child, preschool (16) 16
mortality (16) 16
mutation (16) 16
relapse (16) 16
research (16) 16
care and treatment (15) 15
disease progression (15) 15
europe (15) 15
graft vs host disease - etiology (15) 15
hematopoietic stem cell transplantation - adverse effects (15) 15
medical and health sciences (15) 15
medicin och hälsovetenskap (15) 15
protein-tyrosine kinases - antagonists & inhibitors (15) 15
tyrosine kinase inhibitors (15) 15
bcr-abl transcripts (14) 14
cells (14) 14
infant (14) 14
medicine (14) 14
pyrimidines - administration & dosage (14) 14
animals (13) 13
chronic myeloid leukaemia (13) 13
disease (13) 13
graft vs host disease - prevention & control (13) 13
interferon-alpha (13) 13
medicine, research & experimental (13) 13
multiple myeloma - mortality (13) 13
piperazines - administration & dosage (13) 13
risk (13) 13
article (12) 12
blast crisis (12) 12
chronic phase (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Wahl, Simone and Drong, Alexander and Lehne, Benjamin and Loh, Marie and Scott, William R and Kunze, Sonja and Tsai, Pei-Chien and Ried, Janina S and Zhang, Weihua and Yang, Youwen and Tan, Sili and Fiorito, Giovanni and Franke, Lude and Guarrera, Simonetta and Kasela, Silva and Kriebel, Jennifer and Richmond, Rebecca C and Adamo, Marco and Afzal, Uzma and Ala-Korpela, Mika and Albetti, Benedetta and Ammerpohl, Ole and Apperley, Jane F and Beekman, Marian and Bertazzi, Pier Alberto and Black, S. Lucas and Blancher, Christine and Bonder, Marc-Jan and Brosch, Mario and Carstensen-Kirberg, Maren and De Craen, Anton J.M and De Lusignan, Simon and Dehghan, Abbas and Elkalaawy, Mohamed and Fischer, Krista and Franco, Oscar H and Gaunt, Tom R and Hampe, Jochen and Hashemi, Majid and Isaacs, Aaron and Jenkinson, Andrew and Jha, Sujeet and Kato, Norihiro and Krogh, Vittorio and Laffan, Michael and Meisinger, Christa and Meitinger, Thomas and Mok, Zuan Yu and Motta, Valeria and Ng, Hong Kiat and Nikolakopoulou, Zacharoula and Nteliopoulos, Georgios and Panico, Salvatore and Pervjakova, Natalia and Prokisch, Holger and Rathmann, Wolfgang and Roden, Michael and Rota, Federica and Rozario, Michelle Ann and Sandling, Johanna K and Schafmayer, Clemens and Schramm, Katharina and Siebert, Reiner and Slagboom, P. Eline and Soininen, Pasi and Stolk, Lisette and Strauch, Konstantin and Tai, E-Shyong and Tarantini, Letizia and Thorand, Barbara and Tigchelaar, Ettje F and Tumino, Rosario and Uitterlinden, Andre G and Van Duijn, Cornelia and Van Meurs, Joyce B.J and Vineis, Paolo and Wickremasinghe, Ananda Rajitha and Wijmenga, Cisca and Yang, Tsun-Po and Yuan, Wei and Zhernakova, Alexandra and Batterham, Rachel L and Smith, George Davey and Deloukas, Panos and Heijmans, Bastiaan T and Herder, Christian and Hofman, Albert and Lindgren, Cecilia M and Milani, Lili and Van Der Harst, Pim and Peters, Annette and Illig, Thomas and Relton, Caroline L and Waldenberger, Melanie and Järvelin, Marjo-Riitta and Bollati, Valentina and Soong, Richie and Spector, Tim D and Scott, James and McCarthy, Mark I and ... and Medicinska fakulteten and Science for Life Laboratory, SciLifeLab and Medicinska och farmaceutiska vetenskapsområdet and Molekylär medicin and Uppsala universitet and Institutionen för medicinska vetenskaper
Nature, ISSN 0028-0836, 01/2017, Volume 541, Issue 7635, pp. 81 - 86
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 14, pp. 2381 - 2388
Purpose There is a considerable variability in the level of molecular responses achieved with imatinib therapy in patients with chronic myeloid leukemia (CML).... 
OCT-1 ACTIVITY | THERAPY | CHRONIC-PHASE | ONCOLOGY | KINASE DOMAIN MUTATIONS | STANDARD-DOSE IMATINIB | SUBOPTIMAL RESPONSE | NONADHERENCE | DETERMINANT | CML PATIENTS | BCR-ABL TRANSCRIPTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | RNA, Messenger - metabolism | Young Adult | Time Factors | Aged, 80 and over | Adult | Drug Monitoring - instrumentation | Female | Antineoplastic Agents - pharmacokinetics | Micro-Electrical-Mechanical Systems - instrumentation | Cytogenetic Analysis | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Octamer Transcription Factor-1 - genetics | Piperazines - therapeutic use | Gene Expression Regulation, Leukemic | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | Polymorphism, Genetic | Fusion Proteins, bcr-abl - genetics | Medication Adherence | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - pharmacokinetics | Aged | Benzamides | Mutation | Hema7 | ORIGINAL REPORTS | Hema5
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 06/2010, Volume 7, Issue 6, pp. 303 - 304
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 20, pp. 3358 - 3363
Journal Article
Annals of Hematology, ISSN 0939-5555, 04/2015, Volume 94, Issue 2, pp. 167 - 176
Journal Article